Crispr Therapeutics Viking Therapeutics: 2026 Stock Showdown
As biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
Learn what tax lots are in automated investing, why they matter for cost basis and tax reporting, and how to use them to optimize your portfolios.
14,599 articlesAs biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
A sharp 34% June rally in Sandisk highlights a changing memory market. Explore the forces behind the move, what it me...
When a high-profile investor makes a big move, questions follow. This guide cuts through the headlines to examine Ali...
Big bets on AI infrastructure are reshaping markets. This article dives into whether the Magnificent Seven's plan spe...
Travel stocks rarely move in perfect tandem. This guide weighs Booking Holdings and Marriott International to help yo...
Meta just delivered a major update, but the stock still slid. This article explains what happened, why the move may b...
When Micron announced plans to expand domestic chip production, the stock jumped. This guide breaks down why micron s...
AI is redefining the CMO role, pushing marketing leaders toward broader corporate leadership. In 2026, budgets, gover...
When a CEO buys thousands of shares, investors take note. This article breaks down the 74,000-share purchase by Energ...
Google and Apple are leading the AI stock surge. This piece weighs valuation, growth, and cash flow to answer which m...
Salesforce faces a growth hurdle in a fast-moving AI world. This article explains how a targeted acquisition could fi...
Jim Cramer's ongoing Nvidia purchases rest on one core belief: the CUDA software moat that underpins Nvidia's AI lead...